Cutera (CUTR) Releases Earnings Results, Beats Estimates By $0.09 EPS

Cutera (NASDAQ:CUTR) posted its quarterly earnings data on Wednesday. The medical device company reported $0.42 EPS for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.09, Briefing.com reports. The company had revenue of $47.60 million during the quarter, compared to the consensus estimate of $43.96 million. Cutera had a net margin of 7.99% and a return on equity of 18.73%. The company’s quarterly revenue was up 25.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.30 EPS. Cutera updated its FY18 guidance to $1.03-1.11 EPS.

Cutera (CUTR) opened at $46.65 on Thursday. Cutera has a 52 week low of $18.50 and a 52 week high of $52.90. The firm has a market cap of $636.64, a price-to-earnings ratio of 58.91, a P/E/G ratio of 1.37 and a beta of 0.41.

CUTR has been the topic of a number of research analyst reports. BidaskClub raised shares of Cutera from a “hold” rating to a “buy” rating in a report on Tuesday, December 12th. Maxim Group restated a “hold” rating on shares of Cutera in a research report on Wednesday, November 8th. Finally, Zacks Investment Research upgraded shares of Cutera from a “sell” rating to a “hold” rating in a research report on Tuesday, January 9th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Cutera presently has an average rating of “Buy” and a consensus price target of $37.33.

In related news, insider James A. Reinstein sold 7,175 shares of Cutera stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $45.35, for a total transaction of $325,386.25. Following the completion of the transaction, the insider now owns 132,284 shares of the company’s stock, valued at $5,999,079.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director David B. Apfelberg sold 1,000 shares of Cutera stock in a transaction on Friday, November 17th. The stock was sold at an average price of $42.55, for a total transaction of $42,550.00. Following the transaction, the director now directly owns 8,055 shares of the company’s stock, valued at approximately $342,740.25. The disclosure for this sale can be found here. Insiders have sold 25,018 shares of company stock valued at $1,147,316 in the last three months. 11.60% of the stock is owned by insiders.

WARNING: “Cutera (CUTR) Releases Earnings Results, Beats Estimates By $0.09 EPS” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/15/cutera-cutr-releases-earnings-results-beats-estimates-by-0-09-eps.html.

Cutera Company Profile

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply